Vertex researchers will conduct two 24-week Phase 3 studies on the affect of VX-809 and ivacaftor in CF patients with two copies of the F508del mutation.

Recently, a young man with cystic fibrosis achieved something many never will: a qualifying time to the Boston Marathon.

This year, 30 scholarships totaling $180,000 were given to deserving students who have cystic fibrosis.

In the wake of Hurricane Sandy, Xenith pledged to donate a portion of its online helmet sales to recovery services.

Barrett Jones, center at the University of Alabama, was Named the 2012 Recipient of the Rimington Trophy.

The Champions for Charity event held at over 70 Americana Manhasset and Wheatley Plaza stores benefits over 90 non profits, including the Boomer Esiason Foundation.

Double lung transplant recipient and cystic fibrosis survivor featured on the 23rd Annual CBS Courage in Sports special on Sunday, November 11th.

The NHLBI has launched a program that focuses on infants and young children who have cystic fibrosis that could provide a road map for prevention.

Team Boomer members brought the fight against cystic fibrosis to the streets of Chicago for the 2012 Bank of America Chicago Marathon.

The Cystic Fibrosis Foundation and Walgreens has formed an alliance that will greatly benefit the CF community.

The New York Daily News shares an inspirational story about local “cysters.”

Six outstanding students have been chosen as the 2012 winners of the 2nd quarter BEF $1,000 scholarships.

Dance all night to hits from the 70’s and 80’s to benefit BEF and Team Boomer thanks to Archbishop John Hughes Council #481 DISCO NIGHT 2012.

SUCCESS Magazine features Boomer Esiason, a founder the Boomer Esiason Foundation, as they look back at the creation of the foundation and the reason behind it.

Anna Johnson, Abby Lewis, and Davis Isaaks have been award a $1,000 scholarship for their excellence in creativity and art.

The Anti-Infective Drugs Advisory Committee to the US Food and Drug Administration voted today in favor of the use of TIP by cystic fibrosis patients.

Courtney Robinson has been named the recipient of the $2,000 2012 Rimington Trophy Scholarship.

Sabrina Smith Walker, a 26 year old CF patient and Club CF participant, shares her journey to completing a 15.8 mile Lost Lake Run.

Clayton Roll and Emily Nickels have been named the recipients of the $10,000 Exercise for Life Scholarship.

Tess Dunn, Kiersten Cash, and Thomas Kerekes have been awarded scholarships by the Quigley family.

Researchers at the University of Iowa Carver College of Medicine have discovered a genetic process that can restore function to a defective protein, the most common cause of cystic fibrosis.

Olivia Burke, future student of Heidelberg University, was recently awarded the Bonnie Strangio Education Scholarship in the amount of $2,500 for her excellence in the classroom and her passion for success.

Visit our updated store to find fun, new You Cannot Fail baseball hats as well as other YCF apparel options.

An active lifestyle helped 56-year-old Jerry Cahill stave off the effects of cystic fibrosis. Then doctors told him he needed a lung transplant.

BEF is excited to announce the fall launch of the new Team Boomer website.

The second annual Run to Breathe in Central Park was a huge success, selling out 7,000 spots with close to 5 ,000 runners in attendance the morning of the race.

Jerry Cahill has lived with cystic fibrosis, an incurable genetic disease, for 56 years - 20 years past the median age. Three months ago, he underwent a double lung transplant and on Saturday, July 21, will be running a 10K in Central Park.

Professional surfing legend and accomplished artist, Shawn "Barney" Barron, calls the sport of surfing "conquering the poor man's Everest" and is currently using his art and his position as a surf rep for Volcom to introduce children who suffer from cystic fibrosis to the sport.

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced today final data from a Phase 2 study of VX-809 and KALYDECO™ (ivacaftor) that showed statistically significant improvements in lung function among adults with cystic fibrosis (CF) who have two copies (homozygous) of the most common mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, F508del.

Legislation that will help expedite the approval of safe and effective new rare-disease drugs is making its way through Congress, and advocates hope it soon will be signed by President Obama.

The Boomer Esiason Foundation has released Episode 26 of the CF Wind Sprint series, which discusses how to keep up with your exercise regimen while traveling.

PTC Therapeutics today announced the results from a Phase 3 study of ataluren that demonstrated positive trends in lung function and the rate of pulmonary exacerbations.

The Boomer Esiason Foundation has established the Jerry Cahill You Cannot Fail... You are the Hero of Your Own Story Scholarship to honor exceptional student-athletes with cystic fibrosis who, like Jerry, don’t let the disease get in their way of living lives filled with purpose, passion, optimism and courage.

The Boomer Esiason Foundation encourages outstanding students with cystic fibrosis to apply for five CF scholarships with deadlines in June.

CFChef, an online nutrition destination developed to help meet the unique nutritional needs of people living with cystic fibrosis, has announced four themed recipe contests for 2012, with the first deadlines coming up on June 21.

Boomer reflects on how much brighter the future for the cystic fibrosis community is today than it was when his son was diagnosed nearly two decades ago.

A new podcast from the Boomer Esiason Foundation features an interview with Bobby Bebber, a 28-year-old who has undergone three liver transplants and a kidney transplant but continues to be living, breathing and succeeding with CF.

Gilead Sciences Inc. says it has made progress resolving a shortage of its inhaled antibiotic Cayston® that began earlier this year.

Inhaling concentrated saline mist does not reduce how often infants and young children with CF need antibiotics for respiratory symptoms, according to findings from a recent clinical trial.

Digestive Care, Inc. has received U.S. Food and Drug Administration approval of its new drug application for PERTZYE™, developed for the treatment of exocrine pancreatic insufficiency due to CF or other conditions.

Just over a month after his double-lung transplant, Jerry Cahill tells the complete story of his transplant journey, including how the experience has 'humbled' him.

How much do you know about cystic fibrosis? Test your knowledge with an online CF quiz from Gilead Sciences, and Gilead will make a donation to the Boomer Esiason Foundation and two other CF charities.

The Boomer Esiason Foundation has expanded its storefront on Amazon.com to include sports wristbands and paperweights from the popular You Cannot Fail: You Are the Hero of Your Own Story campaign.

Tickets are on sale now for the second annual New York Yankees celebrity softball event that will benefit the Boomer Esiason Foundation and its fight against cystic fibrosis.

Calling all CF artists! The May 16 application deadline for the Boomer Esiason Foundation's Scholarship of the Arts is coming up quickly, and we encourage all CF student-artists to apply.

The New York Road Runners have opened registration for the 2nd Annual Boomer's Cystic Fibrosis Run to Breathe. The 10K run-walk will be held July 21 in New York City's Central Park and is open to runners at all levels.

Vertex Pharmaceuticals Inc. today announced promising interim results from a Phase 2 clinical trial of its cystic fibrosis drug Kalydeco™ and VX-809, a CF drug in development.

The Boomer Esiason Foundation has received its second consecutive four-star rating from Charity Navigator, an independent evalutator of U.S. philanthropic organizations.

You Cannot Fail: You Are the Hero of Your Own Story — an inspirational book of personal reflections by Boomer Esiason Foundation Volunteer Jerry Cahill — now is available for sale on Amazon.com.

Tickets are on sale now for the Fourth Annual Refi Rock Spring Fling, to be held June 7 at the Central Park Zoo in New York City.

A documentary film on Eva Markvoort, a young Canadian woman who made headlines by blogging about her battle with CF and double-lung transplant, will make its U.S. television premiere on May 3.

Social network Facebook is allowing its 900 million users to share their organ donor status in an effort to spread awareness about the critical need for donated organs.

Jerry Cahill, who received a double-lung transplant in mid-April, shares his thoughts on organ donation, CF Awareness Month and his recently launched You Cannot Fail project.

This year's National Donate Life Month celebration took on new meaning on April 18 when the Boomer Esiason Foundation's Jerry Cahill underwent a double-lung transplant.

A major international research effort has led to a new online resource that provides information about specific cystic fibrosis gene mutations to people with CF and their families, researchers, health professionals and the general public.

Episode 25 of the CF Wind Sprint series focuses on Club CF, a website featuring stories about adults around the country who are living, breathing and succeeding with cystic fibrosis.

This weekend, the Boston College men’s and women’s club lacrosse teams will be facing off against the University of Pittsburgh and Northeastern University in a doubleheader to benefit cystic fibrosis.

The University of Maryland football team's Third Annual "Lift for Life" strength and conditioning competition will benefit the Boomer Esiason Foundation and the cystic fibrosis community.

The Boomer Esiason Foundation is the official charitable partner of the 2012 Atlantic Cup, an annual sailing race that kicks off in Charleston, S.C., on May 11. Enter the Atlantic Cup sweepstakes for a chance to be on board a real race boat during the sprint leg in New York City.

Abbott has announced it will award two $20,000 scholarships to students with cystic fibrosis to celebrate the 20th anniversary of its CFCareForward Scholarship program.

April is National Donate Life Month, a celebration honoring the generosity of organ, eye and tissue donors and their families and commemorating all transplant recipients in the United States.

The Boomer Esiason Foundation has launched a new online shopping cart to make it easier for the cystic fibrosis community and others to purchase merchandise from the "You Cannot Fail: You Are the Hero of Your Own Story" campaign.

The latest cystic fibrosis podcast from the Boomer Esiason Foundation features an interview with 45-year-old Rick Lerz, one year after his double-lung transplant.

It was another great showing for Team Boomer at the 2012 New York City Half-Marathon on March 18. Check out the photos we snapped of our awesome runners in action!

Check out the slideshow from the Second Annual Hoops and Hops for a Cure, held March 15 and organized by the BEF Young Professionals Committee.

PMD Healthcare is encouraging the cystic fibrosis community to enter a sweepstakes contest for a chance to win a personal spirometer.

The CF Wind Sprint series produced by the Boomer Esiason Foundation and BEF Volunteer Jerry Cahill now is available on your iPhone, iPad or iPod Touch.

Episode 24 of our CF Wind Sprint series examines transitioning from college to the career world with cystic fibrosis. It is the third in a three-part series on the major transitioning stages for people with CF.

The FDA has approved Ultresa, a new pancreatic enzyme product used to help aid food digestion in people with cystic fibrosis.

Episode 23 of our CF Wind Sprint series examines transitioning from high school to college with cystic fibrosis. It is the second in a three-part series on the major transitioning stages for people with CF.

The Boomer Esiason Foundation has established the Rimington Trophy Scholarship to recognize outstanding students who are living, breathing and succeeding with cystic fibrosis.

Gilead Sciences says it is working to address "significant and unanticipated challenges manufacturing enough Cayston to meet demand in the United States."

PMD Healthcare Inc. has launched the first and only personal spirometer that enables patients with lung diseases to easily and accurately monitor their lung function any time and anywhere.

Episode 22 of the CF Wind Sprint series examines transitioning from pediatric to adult CF care. It is the first in a three-part series on the major transitions for people with CF.

The Boomer Esiason Foundation has awarded prestigious "Sacks for CF" academic scholarships to 30 outstanding students with cystic fibrosis.

Proceeds from sales of a vintage-style Team Boomer t-shirt, designed by clothing manufacturer Homage, will benefit the Boomer Esiason Foundation and the cystic fibrosis community.

Vertex Pharmaceuticals Inc. announced on January 31 that the FDA has approved KALYDECO™ (ivacaftor), the first medicine to treat the underlying cause of cystic fibrosis.

The 2011 Rimington Trophy was formally awarded to the University of Michigan’s David Molk at the annual presentation event in mid-January. According to Michigan Sports Information Director Justin Dickens, Molk was "the unquestioned leader of our football team."

The Boomer Esiason Foundation's latest video podcast traces Colleen Caul's "Run for Roses" — her 65-day running journey from St. Louis to New York City. Caul's project aims to boost awareness of cystic fibrosis, raises funds toward a cure, and share stories of the CF community.

Vertex Pharmaceuticals is planning additional studies of KALYDECO™ in children with CF and in people with CF who have certain mutationsnot previously evaluated. Pending feedback from regulatory agencies, it plans to begin three studies in mid-2012.

With Gunnar Esiason and his sister, Sydney, both attending Boston College, the Boomer Esiason Foundation has established a $10,000 scholarship to support the studies of a BC student.

Our own Boomer Esiason will be Kelly Ripa's guest co-host on the January 11 "Live! With Kelly" television show.

The 2011 Rimington Trophy will be awarded January 14 to University of Michigan senior David Molk. ESPN.com recently aired a touching profile of Molk, who lost his mother to cancer when he was in eighth grade.

Josh Mogren has launched a campaign using social media to introduce his puppet sidekick, Moganko, to meet the Muppets and, ultimately, raise awareness of cystic fibrosis via a collaborative public service announcement.

Whether your New Year's resolution is running your first 10K, training for a triathlon or conquering a big-city marathon, Team Boomer has an event that will help you meet your fitness goals and support the fight against CF.

The sibling relationship is a special one, and it is especially important in families living with cystic fibrosis. In a brief interview, 19-year-old Sydney Esiason shares some thoughts on being a CF sibling and how BEF is making a difference for all families with CF.

Vintage and collector cars from across the tri-state area recently rolled into the parking lot of Berkeley Collegefor the 7th Annual Charity Car Show. A total of 345 cars were registered in the show, which raised more than $25,000 for the Boomer Esiason Foundation.

According to the CF Foundation, an expanded access program for Kalydeco™ (VX-770) is now available at participating clinical sites for people with the G551D mutation who have highly limited lung function and may benefit from treatment.

Adding inhaled dry powder mannitol to standard CF therapy produced sustained improvement in lung function, according to a new study by Pharmaxis Ltd.

The FDA has granted a request by Vertex Pharmaceuticals for priority review of KALYDECO™, the first potential therapy to target the underlying cause of cystic fibrosis.

The Boomer Esiason Foundation has released Episode 21 of the Cystic Fibrosis Wind Sprint Series, which demonstrates a series of exercises that can be done using equipment called kettlebells.

In recognition of our achievements over the past year, and in anticipation of the challenges we face in the year to come, please consider making an end-of-year donation.

Three new products from the YOU CANNOT FAIL campaign - a hard cover book, t-shirts and wristbands - now are available for purchase online, just in time for holiday gift giving.

University of Michigan senior David Molk has been named the recipient of the 2011 Rimington Trophy, an annual award named for BEF President Dave Rimington.

In the latest podcast from the Boomer Esiason Foundation, 32-year-old Josh Mogren discusses living with cystic fibrosis and cerebral palsy, and how he moved forward after losing his sister to CF.

Scientific American magazine reviews two new research papers - recently published in the journal Science - showing how some bacteria are able to withstand antibiotic treatment.

In addition to Type 1 and Type 2 diabetes, there is another variant of the disease: cystic fibrosis-related diabetes. It differs in some important ways from Type 1 and Type 2 diabetes and it requires different treatment methods.

Genzyme and Cystic Fibrosis Foundation Therapeutics Inc. today announced a research agreement to support the discovery of new drugs to treat people with the most common mutation found in patients with CF, Delta F508.

BEF encourages college students with cystic fibrosis to get started on their application for the General Academic Scholarship. The next application deadline for this program is December 15.

The Boomer Esiason Foundation has unveiled a new, powerful logo for its quickly growing Team Boomer athletic and fundraising program.

Team Boomer, an official charity partner of the 2012 NYC Half-Marathon, is accepting applications for the March 18 event.

Abbott has announced the winners of its recipe contest to launch CFChef, an online resource developed to help meet the unique nutritional needs of people living with cystic fibrosis.

It was another successful ING New York City Marathon, as 115 Team Boomer marathoners brought in more than $500,000 to support cystic fibrosis research and the CF community.

CBS New York featured Team Boomer and the Boomer Esiason Foundation in its coverage of the November 6 New York City Marathon.

Kevin Dwyer, who has cystic fibrosis and will run for Team Boomer in the NYC marathon on Sunday, was profiled in a recent New York Times feature story.

The Boomer Esiason Foundation today announced the sale of limited edition copies of “YOU CANNOT FAIL: You Are the Hero of Your Own Story,” an inspirational book of personal reflections by BEF Volunteer Jerry Cahill.

The Fordham basketball players coached by Boomer Esiason bested the team coached by his WFAN co-host Craig Carton in an intersquad scrimmage that benefited the Boomer Esiason Foundation.

The New England Journal of Medicine features a study this week about a Phase 3 clinical trial of Kalydeco™ (VX-770), a potential CF therapy undergoing review for approval by the U.S. Food and Drug Administration.

The 2011 Refi Rock Halloween event drew more than 800 partygoers. Check out the slideshow from the event!

The Boomer Esiason Foundation encourages college students with cystic fibrosis to get started on their application for the exciting Sacks for CF Scholarship. The application deadline for the program is January 13, 2012.

Vertex Pharmaceuticals today submitted a new drug application to the FDA for KALYDECO™ (VX-770). If approved, the drug will be the first treatment to target the underlying cause of cystic fibrosis.

The Boomer Esiason Foundation has released Episode 20 of the CF Wind Sprint series: Using a Self-Administrator with a Percussor.

A Team Boomer athlete has qualified for the 2012 Olympic Women's Marathon Trials.

Members of the cystic fibrosis community in the Philadelphia area are invited to join Boomer Esiason for "Chalk Talk: CF Education Event" on Monday, November 7.

The New York Road Runners have posted a story on their website about a Team Boomer athlete with CF who is running in the ING New York City Marathon on November 6.

The National Institutes of Health has awarded Agile Sciences a grant to evaluate the efficacy of anti-biofilm molecules for treating lung infections of cystic fibrosis patients.

Insmed Inc.today announced that it has been notified by the FDA that it is continuing the clinical hold previously placed on Insmed's phase 3 clinical trials for ARIKACE® in CF patients with Pseudomonas lung infections.

A new book profiling six Ironman triathletes features Scott Johnson, who has cystic fibrosis.

In our latest podcast, director Marc Smolowitz discusses how “The Power of Two” documentary film is raising awareness of cystic fibrosis and organ donation.

The CF & MS Foundation's upcoming sport fishing and golf tournament in Cabo San Lucas will support the cystic fibrosis and multiple sclerosis communities.

Nick News with Linda Ellerbee hears from kids and families who have been affected by organ donation in the half-hour special, "A Gift of Life," premiering September 18 on Nickelodeon.

Tickets are on sale now for the Fourth Annual Refi Rock Halloween Party with Boomer and Carton! This popular event, hosted by the BEF Young Professionals, brings in funds in support of Team Boomer and other programs supporting the CF community.

The Boomer Esiason Foundation congratulates the Rocky Mountain Silhouettes — and team member Kelsie, who has cystic fibrosis — on their second-place finish in the popular "America's Got Talent" television competition.

The deadline for Abbott's CFChef Challenge recipe contest - open to anyone in the cystic fibrosis community - is September 28.

Boomer Esiason and Craig Carton took their drive-time sports talk radio show to downtown Manhattan this morning, broadcasting live at inter-dealer broker BGC Partners Inc.'s annual BGC Charity Day.

Recently, we tagged along with Jerry Cahill as he spoke to packed house at Children’s Hospital of Wisconsin. In a new podcast, Jerry talks about his no-nonsense approach to managing CF on a daily basis.

In a new video interview for the NFL, Boomer recalls the events of September 11, 2001, and discusses the role football played in helping a grieving country heal.

An exciting performance troupe comprised of young dancers, actors and tumblers — including one with cystic fibrosis — last night made it into the finals of the popular television show "America's Got Talent."

We have teamed up with apparel company Vineyard Vines to create a collection of limited-edition BEF ties and totes. All proceeds from sales of this collection during the month of September benefit the Foundation!

In the attack on the World Trade Center on September 11, 2001, the Boomer Esiason Foundation lost not only its offices, which had been graciously supplied by Cantor Fitzgerald, but also a dear friend and Board member, Timothy O'Brien.

The Boomer Esiason Foundation congratulates the exceptional student-athletes with cystic fibrosis who recently were selected by the Foundation to receive the prestigious Exercise for Life Scholarship for the coming school year.

“The Power of Two,” a feature documentary on twin sisters with cystic fibrosis, has been selected for a prestigious Oscar-qualifying documentary showcase and is kicking off a full

Team Boomer has only a handful of guaranteed entries left for the 2011 ING New York City Marathon. Athletes interested in running for a cause should contact us as soon as possible to secure their registration.

Mark your calendar for the Second Annual Boomer's CF Run to Breathe: Saturday, July 7, 2012. The 10K run/walk, organized by Team Boomer and the New York Road Runners, will be held in NYC's Central Park.

Biotech company Pulmatrix has decided to focus its efforts on PUR118, the company's lead clinical drug candidate for cystic fibrosis and chronic obstructive pulmonary disease.

BEF has released a video recapping Boomer's CF Run to Breathe, the Foundation's first-ever 10K run. The video chronicles this inspirational event, held in July in Central Park.

Congratulations to the exceptional students with cystic fibrosis who recently were selected to receive scholarships for the coming school year. The Foundation awards more than $250,000 in scholarships each year.

The FDA has placed a clinical hold on phase 3 clinical trials for ARIKACE® in cystic fibrosis patients with Pseudomonas lung infections.

The New York Yankees recently presented the Boomer Esiason Foundation with the proceeds raised at the Bombers-Boomer-Broadway Softball Classic.

The Boomer Esiason Foundation has released Episode 19 of the CF Wind Sprint Series: Exercises for the Legs. CF Wind Sprints is a series of brief videos addressing a variety of topics relevant to living with cystic fibrosis.

Volunteers from all over the country will meet with their elected officials in their hometowns this summer as part of Make Every Breath Count, the Cystic Fibrosis Foundation’s annual national advocacy campaign.

August 1 marks the fifteenth anniversary of National Minority Donor Awareness Day, set aside to call attention to the critical need for members of the minority communities to register as organ and tissue donors.

Seventeen-year-old Tyler Nelson, who lives with CF and is waiting for lung and liver transplants, has written a free e-book to promote organ donation and to help teens and young adults cope with serious illness.

Vertex Pharmaceuticals Inc. said it is on track to submit in October a new drug application for VX-770, a promising CF therapy.

A poll by the University of Michigan found that 84 percent of parents say they don't know about opportunities for their children to participate in medical research.

Researchers at the University of Iowa have discovered that in CF patients, the airway glands are depleted of a specific population of airway stem cells that participate in airway repair following injury.

BEF Volunteer Jerry Cahill has received the first annual Distinguished Service Award from Electromed, Inc., maker of the SmartVest® Airway Clearance System.

The Boomer Esiason Foundation has posted a new podcast featuring Jessica Link, 25, who discusses how and why to organize your medical information, and why it's important to be your own patient advocate.

Microbiologists have uncovered a sneaky trick by the bacterium Pseudomonas aeruginosa to oust rivals. Its means of attack helps it survive in the outside environment and may even help it cause infection.

UCLA researchers learn more about how bacteria move across surfaces prior to forming multicellular bacterial biofilms.

To kick off its new CFChef online nutrition resource, Abbott is hosting the "CFChef Challenge" recipe contest, with our own Boomer Esiason as one of the judges.

A study published in the Journal of the American Medical Association says treatment based on a new invasive diagnostic procedure for treating CF in infants did not have a lower prevalence of lung-damaging infection or structural lung injury at age five.

Aptalis Pharma announced that the FDA has approved a new strength of ZENPEP® (pancrelipase) Delayed-Release Capsules for exocrine pancreatic insufficiency.

The results are in and the photos have been uploaded! Check out the wrap-up from the inaugural Boomer's CF Run to Breathe.

Thousands of people turned out for the first-ever Boomer's CF Run to Breathe in Central Park. See the coverage from CBS 2 in New York.

ESPN.com's Big Ten Blog recently featured an interview with BEF President Dave Rimington.

The Boomer Esiason Foundation has posted a new audio podcast featuring Megan Mollahan, a parent in New York who has two children with cystic fibrosis.

Boomer Esiason and Craig Carton will bartend at a festive summer party on Fire Island, raising money to support programs for the CF community.

The Civilian Military Combine – the ultimate test of strength, endurance and agility – will challenge some of the world's most fit athletes while providing support to BEF.

The Boomer Esiason Foundation has released Episode 18 of the CF Wind Sprint Series: Upper Body Exercises.

The first Bombers-Boomer-Broadway Softball Classic combined fun in the sun with some serious fundraising. Check out our photo slideshow from this fantastic event!

Researchers at UCLA have identified a new stem cell that participates in the repair of the large airways of the lungs, which play a vital role in protecting the body from infection.

Boomer Esiason estimated his foundation raised upward of $30,000 today at Yankee Stadium, where he hosted the Bombers Boomer Broadway Softball Classic.

A new clinical report provides detailed guidance to pediatricians, family physicians, and internists to support all adolescents, including those with special health care needs, as they transition to an adult model of health care.

Photos from the 16th Annual UnitedHealthcare Empire Challenge now are available online. Check out the Empire Challenge slideshow, view and order prints, and share them with your friends.

The Third Annual Refi Rock Spring Fling ROCKED the Statue of Liberty earlier this month! Check out the video and slideshow from the event.

BEF's own Gunnar Esiason and Jerry Cahill are preparing to participate in the inaugural Boomer's CF Run to Breathe, showing that exercise really does make a difference for people with CF, no matter what their age.

In a thrilling contest that pitted the best high school football players from Long Island against their counterparts from New York City, the Long Islanders earned a 17-14 victory Tuesday night in the 16th Annual UnitedHealthcare Empire Challenge All-Star Game.

A young Irish woman made history twice by being the first patient to have a lung transplant while suffering from multi-resistant Aspergillus, a common airborne fungus, and multiple fungal balls in her old lungs.

Researchers at Duke University Medical Center have made new discoveries about mouse basal cells that line airways which could help provide new therapies for either blocked or thinned airways.

Scientists may have discovered an entirely new way to change the genetic code. The findings may ultimately help researchers alter the course of devastating genetic disorders, such as cystic fibrosis.

The FDA has approved an infant-specific dose of Abbott's CREON® (pancrelipase) Delayed-Release Capsules to treat exocrine pancreatic insufficiency due to cystic fibrosis.

Mutations in genes essential to survival are behind so-called orphan diseases, explaining in part why these diseases are rare and often deadly, according to a study appearing in The American Journal of Human Genetics.

Vertex Pharmaceuticals announced a plan to provide VX-770, a cystic fibrosis medicine in development, to people with the G551D mutation who are in critical medical need and may benefit from treatment prior to potential approval of the drug from the U.S. Food and Drug Administration.

Vertex Pharmaceuticals reported positive final results of a Phase 3 clinical trial of VX-770, a CF medicine in development that targets the underlying cause of the disease.

Vertex Pharmaceuticals announced promising results from a Phase 2 study evaluating combinations of VX-770 and VX-809, potential medicines designed to treat the defective protein that causes cystic fibrosis.

Aradigm Corp. has received orphan drug designation from the FDA for ciprofloxacin for inhalation for the management of bronchiectasis.

The U.S. Department of Health and Human Services recently announced new steps to reduce premiums and make it easier for Americans to enroll in the Pre-Existing Condition Insurance Plan.

Longtime Boomer Esiason Foundation volunteer Jerry Cahill last night was inducted into the Catholic High School Athletic Association Hall of Fame for his contributions as a pole vault coach at Iona Preparatory School.

Tickets are on sale now for an exclusive June 27 New York Yankees celebrity softball event that will benefit the Boomer Esiason Foundation and its fight against cystic fibrosis.

Cystic fibrosis families believe in the power of exercise. Here's an inspiring collection of photos showing their kids engaging in a variety of sports and other activities.

A growing shortage of medications for a host of illnesses — including cystic fibrosis — has hospitals scrambling for substitutes to avoid patient harm, and sometimes even delaying treatment.

A bacteria which infects people with cystic fibrosis could help combat other antibiotic-resistant microbes, according to a team from Cardiff and Warwick Universities in Great Britain.

WFAN’s morning drive duo of Boomer Esiason and Craig Carton will have to switch gears — from debating the merits of the Mets to the deliciousness of dishes — for their appearance this Sunday, May 29, on the Food Network’s “Iron Chef America.”

UnitedHealthcare has agreed to sponsor the 16th Annual Empire Challenge, which showcases the best high school football players from New York City and Long Island while raising funds to help fight cystic fibrosis.

As part of its CF Awareness Month focus on exercise, the Boomer Esiason Foundation has released Episode 17 in the Cystic Fibrosis Wind Sprint series: Using the PowerLung.

WCBS-TV in New York soon will air a public service announcement promoting Boomer's Cystic Fibrosis Run to Breathe, a 10K run in Central Park on July 9.

Researchers at the Johns Hopkins Institute for Genetic Medicine have discovered two regions of the genome that affect the severity of cystic fibrosis.

Children's Hospital of Philadelphia tops the list of top-ranked pediatric hospitals for pulmonology in the 2011-12 U.S. News rankings of best children's hospitals.

A genetic test from Abbott provides information used for cystic fibrosis carrier screening, newborn screening and confirmation of CF diagnoses in newborns and children.

The Boomer Esiason Foundation has posted a new video podcast featuring Valerie Batz, a 52-year-old with cystic fibrosis who discusses life before and after a double-lung transplant.

Registering for a local race can be a little scary, especially if you’ve never before run a road race. But setting a goal – like running your first 5K – is a great way to start a fitness program and, hopefully, a healthier lifestyle. It also gives you the opportunity to support the cystic fibrosis community by running for a cause.

Test your cystic fibrosis knowledge and show your support for the Boomer Esiason Foundation by taking the "What's Your CF IQ?" quiz sponsored by Gilead Sciences.

Canadian high school student Marshall Zhang used the Canadian SCINET supercomputing network to find a potentially effective drug cocktail to treat cystic fibrosis.

BEF Volunteer Jerry Cahill on May 7 received the Ellis Island Medal of Honor, awarded annually to American citizens of diverse origins for their outstanding contributions to their communities, their nation and the world.

The Boomer Esiason Foundation has posted a new video podcast featuring Kay W., who discusses how she lives life to the fullest as a 49-year-old with cystic fibrosis.

WBUR's "Common Health" takes a closer look at the Vertex drug VX-770 in its recent special report, "New Cystic Fibrosis Drug Brings Gift of a Future."

The Boomer Esiason Foundation has released Episode 16 in the CF Wind Sprint series: Cardio Exercises. In the video, BEF Volunteer Jerry Cahill shares his favorite simple cardio exercises that help keep the lungs clear of mucus.

A Johns Hopkins Children's Center study of kids with CF shows that simple exercise, individually tailored to each patient’s preference and lifestyle, can help improve lung function and overall fitness.

The New York Road Runners today opened registration for the inaugural Boomer's CF Run to Breathe, a 10K run/walk to be held July 9 in Central Park.

May is CF Awareness Month, and this year, the Boomer Esiason Foundation is encouraging the CF community to take advantage of the power of exercise. Watch Jerry Cahill's kick-off video for more information.

Episode 15 of the CF Wind Sprint series focuses on stretching before exercise to help improve blood flow, prevent injuries and improve breathing.

An over-the-counter drug used to treat diarrhea combined with minocycline, an antibiotic used to treat bacterial infections, could one day change the lives of those living with cystic fibrosis.

The FDA has rejected Eli Lilly and Co.'s EPI drug candidate liprotamase and has ordered the company to conduct additional clinical trials on the potential therapy.

The New York Organ Donor Network kicked off National Donate Life Month with a campaign – headlined by Boomer Esiason and Grizz Chapman – to increase organ donation registrations in the state.

The Boomer Esiason Foundation has posted CF Podcast 101: Motivation - Before and After a Lung Transplant. The podcast features Dottie Lessard, who continues to achieve and re-invent herself 16 years post-double-lung transplant.

What would it be like to be born with a target on your chest? A bull’s-eye stamped with a number smack in the middle of the hub? Tim Wotton knows. Gunnar Esiason too.

The CF Foundation is expandin its collaboration with Vertex Pharmaceuticals for the discovery and development of additional drugs aimed at treating the underlying cause of cystic fibrosis.

Researchers from IBM and the Institute of Bioengineering and Nanotechnology discovered a nanomedicine breakthrough in which new types of polymers were shown to physically detect and destroy antibiotic-resistant bacteria and infectious diseases like Methicillin-resistant Staphylococcus aureus, known as MRSA.

A new law that allows patients with rare diseases to participate in clinical trials without losing eligibility for public healthcare benefits has gone into effect.

Increased referrals from around the country and surgeons' ability to use donor lungs once considered unsuitable contributed to a record 131 lung transplants at University of Pittsburgh Medical Center last year.

Read the complete Vertex Pharmaceuticals press release on its recent findings in the Phase 3 clinical trial of VX-770.

Vertex Pharmaceuticals reports positive results from Phase 3 clinical trial of VX-770 for children age 6 to 11.

Episode 14 of the CF Wind Sprint series focuses on strengthening your core muscles in order to make your coughs more productive.

A pig model that replicates the most common form of CF can be useful in learning about the CFTR protein's properties, researchers have found.

Researchers soon will explore 4-D imaging of lungs in young children with CF.

Applications for the Boomer Esiason Foundation's general academic scholarship are due March 15.

An FDA advisory panel said March 8 that genetic tests directly marketed to consumers should be allowed only under a doctor's supervision.

The Boomer Esiason Foundation has released a new video to encourage people to join Team Boomer and run for a cause.

Vertex Pharmaceuticals Inc. announced positive results from the Phase 3 STRIVE study of VX-770, a potential therapy that targets the defective protein that causes CF.

Axcan President and CEO Frank Verwiel explains how Axcan's merger with Eurand will affect customers.

An FDA advisory committee voted to recommend non-approval of liprotamase, currently under FDA review for the treatment of exocrine pancreatic insufficiency.

Mpex Pharmaceuticals, Inc., today announced it has initiated its Phase 3 clinical trial program with Aeroquin? (MP-376) for the treatment of pulmonary infections in patients with cystic fibrosis.

Inspire Pharmaceuticals, Inc. today announced disappointing results from its second Phase 3 clinical trial, TIGER-2, with denufosol tetrasodium for the treatment of cystic fibrosis.

PTC Therapeutics, Inc. announced today that it has completed enrollment of a Phase 3 clinical trial of ataluren, an investigational new drug, in patients with nonsense mutation cystic fibrosis (nmCF).

Inspire Pharmaceuticals, Inc. announced today that the results from its first Phase 3 clinical trial with denufosol tetrasodium for cystic fibrosis, TIGER-1, have been published in the American Journal of Respiratory and Critical Care Medicine.

Texas Christian University senior Jake Kirkpatrick has been named the recipient of the 2010 Rimington Trophy. The Trophy, named for Boomer Esiason Foundation President David B. Rimington, is awarded annually to the most outstanding center in NCAA Division I-A football.

The Boomer Esiason Foundation has joined with Samsung Hope for Children, the national philanthropic initiative of the world's technology leader, and Sears to launch a new social action campaign, "Tackle CF with Boomer Esiason." The new initiative will benefit the former NFL quarterback's foundation, which supports medical research to find a cure for cystic fibrosis (CF) and also helps provide a better quality of life for those affected by the chronic disease.

In a study published in this week's New England Journal of Medicine, treatment with a new drug candidate known as VX-770 resulted in improvements in lung function and markers of disease in a Phase 2 clinical trial of 39 people with cystic fibrosis.

PTC Therapeutics, Inc. today announced the publication of data from a Phase 2a clinical trial of ataluren in children with nonsense mutation cystic fibrosis (nmCF) in the American Journal of Respiratory and Critical Care Medicine. The published data show that treatment with ataluren, an investigational new drug, resulted in statistically significant improvements in the production and function of cystic fibrosis transmembrane conductance regulator (CFTR), a critical protein lacking in CF patients.

An imbalance of salt and water in patients with cystic fibrosis makes their lungs clog up with sticky mucus that is prone to infection. The cause of the offending imbalance is a well-known genetic error, one that blocks the molecular expressway for tiny chloride ions to move across the surface of the lungs. But how does that same gene mutation upset a parallel roadway controlling the flow of the other component of salt, sodium ions?

A new study using a pig model of cystic fibrosis (CF) suggests that low levels of a growth promoting hormone at or before birth may contribute to growth defects in patients with CF.

Discovery Laboratories, Inc. today announced that the Office of Orphan Products Development of the United States Food and Drug Administration (FDA) has granted orphan drug designation to Discovery's KL4 surfactant for the treatment of cystic fibrosis (CF). Orphan designation provides for up to seven years of U.S. market drug product exclusivity for the designated indication following marketing authorization.

Pharmaceutical company Pharmaxis today announced significant results of pooled data from its two large scale six month Phase III trials of Bronchitol (inhaled mannitol) in people with cystic fibrosis.

Gilead Sciences, Inc. announced that its head-to-head Phase III clinical trial of Cayston® (aztreonam for inhalation solution) versus tobramycin inhalation solution in cystic fibrosis patients with Pseudomonas aeruginosa achieved its co-primary endpoint of superiority of Cayston for mean actual change in forced expiratory volume in one second (FEV1, a measure of lung function) percent predicted across three treatment cycles (six months).

A new analysis of data from more than 12,000 people with cystic fibrosis (CF) and Pseudomonas aeruginosa (Pa) lung infection in the Cystic Fibrosis Foundation's Patient Registry shows that use of TOBI(R) (Tobramycin Inhalation Solution, USP) was associated with a 21% reduction in mortality in the following year. The results were presented today at the 24th Annual North American Cystic Fibrosis Conference (NACFC) in Baltimore, Maryland, sponsored by the Cystic Fibrosis Foundation.

Vertex Pharmaceuticals Inc. today announced the initiation of a Phase 2a clinical trial that will evaluate multiple combinations of VX-770 and VX-809, investigational oral cystic fibrosis transmembrane conductance regulator (CFTR) modulators for the treatment of cystic fibrosis. The trial is designed to evaluate the safety and tolerability of VX-809 dosed alone for 14 days followed by dosing of VX-809 in combination with VX-770 for 7 days. The trial will also assess the effect of VX-809 alone and in combination with VX-770 on CFTR function, as measured by sweat chloride. The three-part trial is designed to enroll up to a total of 160 people with two copies of the F508del CFTR mutation, the most common mutation in the CFTR gene.

Note from BEF: This Metabolon press release details a newly published research paper. The paper's findings "reveal novel metabolic abnormalities associated with the CF pathological process and identify a panel of potential biomarkers for therapeutic development using this model system," according to Metabolon. The company's metabolomics-driven approach enables the identification of biomarkers useful for the development of a wide range of diagnostics and provides insight into complex biochemical processes such as drug action, toxicology and bioprocess optimization.

A new study links flare-ups of cystic fibrosis to a chronic bacterial infection, a finding that could give physicians new insight into the disease and offer a new target for medication.

Human growth hormone can be used successfully to treat some symptoms of cystic fibrosis, but its impact on the disease itself remains unknown, according to a new report funded by U.S. Department of Health and Human Services' Agency for Healthcare Research and Quality (AHRQ).

A University of Texas at Austin College of Pharmacy researcher has received a $2.1 million grant to develop new techniques for drug delivery to the lungs, helping in the fight against such lung diseases as cystic fibrosis.

The U.S. House of Representatives passed the "Improving Access to Clinical Trials Act" (I-ACT), in a victory for the Cystic Fibrosis Foundation, its advocates and 120 other health advocacy organizations.

PTC Therapeutics, Inc. announced a grant award of approximately $1.6 million from the U.S. Food and Drug Administration Office of Orphan Products Development to support an ongoing Phase 3 study of ataluren in patients with nonsense mutation cystic fibrosis.

The Boomer Esiason Foundation is pleased to announce that the cystic fibrosis podcast series produced by BEF Volunteer Jerry Cahill now is available on your iPhone, iPad or iPod Touch.

Vitamin D may be an effective therapy to treat and even prevent allergy to a common mold that can cause severe complications for patients with cystic fibrosis and asthma, according to researchers from Children's Hospital of Pittsburgh of UPMC, the University of Pittsburgh School of Medicine and Louisiana State University School of Medicine.

Luminex Corp. announced the full commercial launch of a new diagnostic test that can simultaneously screen a single blood sample for up to 60 cystic fibrosis-causing genetic mutations in a matter of hours.

The Boomer Esiason Foundation has awarded $10,000 scholarships to two college freshmen with cystic fibrosis.

You don't have to be rich, famous or even an adult to leave a memorable legacy that can change lives.

The U.S. Senate last night passed the "Improving Access to Clinical Trials Act," a bipartisan piece of legislation championed by the Cystic Fibrosis Foundation, its advocates and 120 other health advocacy organizations.

Emily Schaller likes to travel as part of the cystic-fibrosis advocacy she does, but the daily regimen she uses to manage her disease weighs her down. "You have to bring three extra bags with meds and the vest," she said.

Eurand Pharmaceuticals, a subsidiary of specialty pharmaceutical company Eurand, has announced additional data from a post-hoc analysis of a Phase III clinical trial with Zenpep delayed-release capsules, an FDA-approved pancreatic enzyme product, or PEP, for the treatment of exocrine pancreatic insufficiency in patients with cystic fibrosis or other conditions.

A 'best' hospital for CF kids: unhappy with its so-so record, Cincinnati Children's used tools of health reform to turn itself around.

A retrospective analysis of more than 1,500 patients suggests nothing is gained by extending intravenous (IV) antibiotic treatment beyond 8 to 10 days, or by giving antibiotics in the hospital.

Eli Lilly and Company and Alnara Pharmaceuticals, Inc. today announced they have signed a definitive merger agreement whereby Lilly will acquire Alnara, a privately held biotechnology company developing protein therapeutics for the treatment of metabolic diseases.

A study published today in the Journal of the American Medical Association examines the effect that methicillin-resistant Staphylococcus aureus (MRSA) has on people with cystic fibrosis. It found that chronic infection with MRSA in people with CF was associated with worse survival than those who don't have the bacteria.

Ten years after President Bill Clinton announced the completion of the first draft of the Human Genome Project, its application to drug development is still, at best, a work in progress. But while many genetics scientists outside the drug industry say the project has had few medical benefits, industry researchers urge a wait-and-see patience.

The CF Foundation has learned that the U.S. Food and Drug Administration will allow wholesalers to distribute the pancreatic enzyme product Pancrease® MT to pharmacies until July 12, 2010. At that time, an updated formula called PancreazeTM will become available and will replace Pancrease.

The Cystic Fibrosis Foundation has learned that the pancreatic enzyme product Pancrease will be available in limited supply at pharmacies around the country until an updated formula called Pancreaze is made available this summer.

Inspire Pharmaceuticals Inc. announced today that Inspire scientists will present data suggesting that denufosol, an inhaled ion channel regulator, has properties that allow it to reach and improve lung function in the small airways, which may support its potential as an early intervention therapy.

Mpex Pharmaceuticals, Inc. today announced the presentation of data from its Phase 2b clinical trial with Aeroquin that demonstrated statistically significant improvements in bacterial load, respiratory function and time to need for anti-pseudomonal antibiotics versus placebo in a heavily treated patient population.

Children and adolescents with cystic fibrosis who received the antibiotic azithromycin did not experience improved lung function, compared with patients who received placebo, according to a study published in the May 5 issue of the Journal of the American Medical Association.